Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

被引:256
作者
Merriman, Raphael B.
Ferrell, Linda D.
Patti, Marco G.
Weston, Shiobhan R.
Pabst, Mark S.
Aouizerat, Bradley E.
Bass, Nathan M.
机构
[1] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA
关键词
D O I
10.1002/hep.21346
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In the absence of surrogate markers, the evaluation of suspected nonalcoholic fatty liver disease (NAFLD) is highly dependent on histological examination. The extent of sampling variability affecting the reliability of a single liver biopsy in patients with suspected NAFLD is poorly characterized. This prospective study aimed to correlate precise histological findings in paired biopsies-right and left lobe-in the diagnosis of NAFLD in morbidly obese subjects undergoing bariatric surgery employing both Brunt and Matteoni classifications and the NAFLD Activity Score (NAS). We also aimed to determine whether the composite histopathological findings of the two biopsies would improve diagnostic accuracy. Consecutive subjects had an intraoperative biopsy from both right and left lobes, evaluated and scored in a blinded manner. Intraobserver agreement was also assessed. Kappa coefficients of agreement were calculated. Forty-one subjects had acceptable biopsies. Agreement for steatosis was excellent and moderate for fibrosis. Concordance was only fair for most features of necroinflammation. Intraobserver agreement was only moderate for lobular inflammation. Excellent agreement was seen for the diagnosis of NASH using Brunt criteria and good agreement when using Matteoni and NAS scoring systems. Composite biopsy data particularly improved identification of hepatocyte ballooning. The diagnostic accuracy also improved substantially when composite features were compared with single-sided biopsy features, especially for the Matteoni and NAS scoring systems. In conclusion, significant sampling variability occurs in NAFLD, particularly for features of necroinflammation. This should be factored into the design of clinical trials and studies of the natural history of the disease.
引用
收藏
页码:874 / 880
页数:7
相关论文
共 21 条
  • [11] MEASUREMENT OF OBSERVER AGREEMENT FOR CATEGORICAL DATA
    LANDIS, JR
    KOCH, GG
    [J]. BIOMETRICS, 1977, 33 (01) : 159 - 174
  • [12] Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
    Lindor, KD
    Kowdley, KV
    Heathcote, EJ
    Harrison, ME
    Jorgensen, R
    Angulo, P
    Lymp, JF
    Burgart, L
    Colin, P
    [J]. HEPATOLOGY, 2004, 39 (03) : 770 - 778
  • [13] Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
    Matteoni, CA
    Younossi, ZM
    Gramlich, T
    Boparai, N
    Liu, YC
    McCullough, AJ
    [J]. GASTROENTEROLOGY, 1999, 116 (06) : 1413 - 1419
  • [14] Mendez P, 2003, HEPATOLOGY, V38, p673A
  • [15] Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone
    Neuschwander-Tetri, BA
    Brunt, EM
    Wehmeier, KR
    Oliver, D
    Bacon, BR
    [J]. HEPATOLOGY, 2003, 38 (04) : 1008 - 1017
  • [16] Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference
    Neuschwander-Tetri, BA
    Caldwell, SH
    [J]. HEPATOLOGY, 2003, 37 (05) : 1202 - 1219
  • [17] A pilot study of ploglitazone treatment for nonalcoholic steatohepatitis
    Promrat, K
    Lutchman, G
    Uwaifo, GI
    Freedman, RJ
    Soza, A
    Heller, T
    Doo, E
    Ghany, M
    Premkumar, A
    Park, Y
    Liang, TJ
    Yanovski, JA
    Kleiner, DE
    Hoofnagle, JH
    [J]. HEPATOLOGY, 2004, 39 (01) : 188 - 196
  • [18] Sampling variability of liver biopsy in nonalcoholic fatty liver disease
    Ratziu, V
    Charlotte, F
    Heurtier, A
    Gombert, S
    Giral, P
    Bruckert, E
    Grimaldi, A
    Capron, F
    Poynard, T
    [J]. GASTROENTEROLOGY, 2005, 128 (07) : 1898 - 1906
  • [19] Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x
  • [20] A Pilot Study of Vitamin E Versus Vitamin E and Pioglitazone for the Treatment of Nonalcoholic Steatohepatitis
    Sanyal, Arun J.
    Mofrad, Pouneh S.
    Contos, Melissa J.
    Sargeant, Carol
    Luketic, Velimir A.
    Sterling, Richard K.
    Stravitz, R. Todd
    Shiffman, Mitchell L.
    Clore, John
    Mills, Alan S.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (12) : 1107 - 1115